Role of baicalin in regulating Toll-like receptor 2/4 after ischemic neuronal injury

Chinese Medical Journal

Volumn 125, Issue 9, 2012, Pages 1586-1593

  Li, Hui Ying ^a   Yuan, Zhi Yi ^a   Wang, Yu Gang ^a   Wan, Hong Jiao ^b   Hu, Jun ^a   Chai, Yu Shuang ^a   Lei, Fan ^a   Xing, Dong Ming ^a   Du, Li Jun ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Jiangxi University of Traditional   (China)

Author keywords

Baicalin; Cerebral ischemia reperfusion; Neuron; Oxygen glucose deprivation; Toll like receptor 2 4

Indexed keywords

BAICALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; MALE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BRAIN ISCHEMIA; CELLS, CULTURED; FEMALE; FLAVONOIDS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED ICR; NEURONS; NF-KAPPA B; PC12 CELLS; RATS; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863200124     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.09.012     Document Type: Article

References (33)

1. Nagahiro S, Uno M, Sato K, Goto S, Morioka M, Shio UY. Pathophysiologyand treatment of cerebral ischemia. J Invest Med 1998; 45: 57-70.
2. Perera MN, Ma HK, Arakawa S, Howells DW, Markus R, Rowe CC, et al. Inflammation following stroke. J Clin Neurosci 2006; 13: 1-8.
3. Ridder DA, Schwaninger M. NF-kappa B singnaling in cerebral ischemia. J Neurosci 2009; 156: 995-1006.
4. Campos MA, Gazzinelli RT. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors. Mediators Inflamm 2004; 13: 139-143.
5. Medhzitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
6. Napoli I, Neumann H. Microglial clearance function in health and disease. J Neurosci 2009; 158: 1030-1038.
7. Ock J, Kim S, Yi KY, Kim NJ, Han HS, Cho JY, et al. A novel anti-neuroinflammatory pyridylimidazole compound KR-31360. Biochem Pharmacol 2010; 79: 596-609.
8. Teeling JL, Perry VH. System infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. J Neurosci 2009; 158: 1062-1073.
9. Tang SC, Lathia JD, Selvaraj PK, Jo DG, Mughal MR, Cheng AW, et al, Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp Neurol 2008; 213: 114-121.
10. Li HY, Hu J, Ma L, Yuan ZY, Wang YG, Wang XK, et al. Comprehensive study of baicalin down-regulating NOD2 receptor expression of neurons with oxygen-glucose deprivation in vitro and cerebral ischemia-reperfusion in vivo. Eur J Pharmacol 2010; 649: 92-99.
11. Chang CP, Huang WT, Cheng BC, Hsu CC, Lin MT. The flavonoid baicalin protects against cerebrovascular dysfunction and brain inflammation in experimental heatstroke. Neuropharmacology 2007; 52: 1024-1033.
12. Zhang ZJ, Li P, Wang Z, Li PT, Zhang WS, Sun ZH, et al. A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemiareperfusion injury. Brain Res 2006; 1123: 188-195.
13. Chen YC, Chow JM, Lin CW, Wu CY, Shen SC. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol Appl Pharmcol 2006; 216: 263-273.
14. Lee HH, Yang LL, Wang CC, Hu SY, Chang SF, Lee YH. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate-and glucose deprivation-induced neuronal death. Brain Res 2003; 986: 103-113.
15. Li BQ, Fu T, Gong WH, Dunlop N, Kung HF, Yan YD, et al. The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 2000; 49: 295-306.
16. Hua F, Ma J, Ha TZ, Kelley JL, Kao RL, Schweitzer JB, et al. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res 2009; 1262: 100-108.
17. Clark IA, Alleva LM, Vissel B. The roles of TNF in brain dysfunction and disease. Pharmacol Ther 2010; 128: 519-548.
18. Evans NA, Facci L, Owen DE, Soden PE, Burbidge SA, Prinjha RK, et al. A beta (1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis. J Neurosci Meth 2008; 175: 96-103.
19. Zhao YN, Shen J, Su H, Huang YF, Xing DM, Du LJ. Long-term exposure to high corticosterone levels inducing a decrease of adenylate kinase 1 activity. Tsinghua Sci Tech 2009; 14: 519-527.
20. Du LJ, Yu L, Ma LY, Sun SM, Jin W. Miningeal blood flow by incomplete reansient cerebral ischemia reperfusion and the effect of nimodipine in mice. Chin Pharmacol Bull 1997; 13: 223-226.
21. Xing DM, Guo YY, Yan B, Wang DY, Wang YG, Du LJ. Model establishment of post-stroke depression in mice. Chin J Compara Med 2009; 19: 14-19.
22. Hailer NP. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 2008; 84: 211-233.
23. Li Y, Li H, Zhang Y, Sun XL, Hanley GA, LeSage G, et al. Toll-like receptor 2 is required for opioids-induced neuronal apoptosis. Biochem Biophys Res Commun 2010; 391: 426-430.
24. Okun E, Griffioen KJ, Son TG, Lee JH, Roberts NJ, Mughal MR, et al. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J Neurochem 2010; 114: 462-474.
25. Na HY, Mazumdar K, Moon HJ, Chang S, Seong SY. TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation. Cell Immunol 2009; 259: 33-40.
26. Zhang L, Xing DM, Wang W, Wang R, Du LJ. Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Scutellariae Radix extract. J Ethnopharmacol 2006; 103: 120-125.
27. Doyle SL, O'Neill LA. Toll-like receptors: From the discovery of NF-κB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006; 72: 1102-1113.
28. Gao Y, Fang XB, Tong Y, Liu YL, Zhang BH. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed Pharmacother 2009; 63: 442-450.
29. Ruslan M. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-145.
30. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, et al. In vivo expression of toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α, ediated up-regulation during inflammation. J Immunol 2002; 168: 1286-1293.
31. Zeng LX, Dong JC, Yu WQ, Huang JH, Liu BJ, Feng XT. Baicalin attenuates inflammation by inhibiting NF-kB activation in cigarette smoke induced inflammatory models. Pulm Pharmacol Ther 2010; 23: 411-419.
32. Frank S, Copanaki E, Burbach GJ, Müller UC, Deller T. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice. Neurosci Lett 2009; 453: 41-44.
33. Letiembre M, Liu Y, Walter S, Hao W, Pfander T, Wrede A, et al. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurochem 2010; 114: 462-474.